Towards All-Non-Vacuum-Processed Photovoltaic Systems: A Water-Based Screen-Printed Cu(In,Ga)Se 2 Photoabsorber with a 6.6% Efficiency.
Bruna F GonçalvesViviana SousaJosé VirtuosoEvgenii ModinOleg I LebedevGabriela BotelhoSascha SadewasserLaura M SalonenSenendxu Lanceiros-MéndezYury V Kolen'koPublished in: Nanomaterials (Basel, Switzerland) (2023)
During the last few decades, major advances have been made in photovoltaic systems based on Cu(In,Ga)Se 2 chalcopyrite. However, the most efficient photovoltaic cells are processed under high-energy-demanding vacuum conditions. To lower the costs and facilitate high-throughput production, printing/coating processes are proving to be effective solutions. This work combined printing, coating, and chemical bath deposition processes of photoabsorber, buffer, and transparent conductive layers for the development of solution-processed photovoltaic systems. Using a sustainable approach, all inks were formulated using water and ethanol as solvents. Screen printing of the photoabsorber on fluorine-doped tin-oxide-coated glass followed by selenization, chemical bath deposition of the cadmium sulfide buffer, and final sputtering of the intrinsic zinc oxide and aluminum-doped zinc oxide top conductive layers delivered a 6.6% maximum efficiency solar cell, a record for screen-printed Cu(In,Ga)Se 2 solar cells. On the other hand, the all-non-vacuum-processed device with spray-coated intrinsic zinc-oxide- and tin-doped indium oxide top conductive layers delivered a 2.2% efficiency. The given approaches represent relevant steps towards the fabrication of sustainable and efficient Cu(In,Ga)Se 2 solar cells.
Keyphrases
- solar cells
- oxide nanoparticles
- pet ct
- high throughput
- metal organic framework
- quantum dots
- single cell
- aqueous solution
- positron emission tomography
- highly efficient
- induced apoptosis
- stem cells
- reduced graphene oxide
- tissue engineering
- low cost
- visible light
- heavy metals
- cell therapy
- cell proliferation
- cell cycle arrest
- signaling pathway
- risk assessment
- bone marrow